LENZ Therapeutics, Inc. maintains a speculative but strong buy for small positions, citing favorable risk/reward. Learn more ...
Proven and Probable (P&P) Mineral Reserves kept stable when compared with the F1 2025 report. Although comparing with 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results